AZENTA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.51 USD | -2.89% |
|
-0.11% | -19.39% |
Presenter SpeechUnknown Analyst (Analysts)Hi. Good afternoon. I'm Fernando Marin, Executive Di...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Azenta, Inc. is a provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Companyâs segments include Sample Management Solutions, Multiomics and B Medical Systems. The Sample Management Solutions segment offers end-to-end sample management products and services, including sample and repository services and core products (automated stores, cryogenic systems, automated sample tube, and consumables and instruments). The Multiomics segment provides genomic and other sample analysis services, including gene sequencing and gene synthesis. B Medical Systems segment is focused on the manufacturing and distribution of temperature-controlled storage and transportation solutions in international markets to governments, health institutions, and non-government organizations. It provides products and services through its brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey, and B Medical Systems.
Calendar
2024-08-05
- Q3 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
54.07
USD
Average target price
66.8
USD
Spread / Average Target
+23.54%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -19.39% | 3.02B | |
| +23.37% | 46.71B | |
| +48.83% | 41.8B | |
| -0.94% | 41.52B | |
| -5.86% | 29.55B | |
| +11.29% | 25.78B | |
| -20.92% | 19.26B | |
| +3.20% | 12.14B | |
| -2.67% | 12.08B | |
| +30.23% | 11.98B |
- Stock Market
- Equities
- AZTA Stock
- News Azenta, Inc.
- Transcript : Azenta, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-13-2023 02